Four touch down in Enzo
This article was originally published in Scrip
Executive Summary
Enzo Life Sciences, a subsidiary of Enzo Biochem, has appointed four executives to newly created positions: Dr Bruce Taillon from Roche Diagnostics' 454 Life Sciences Division joins as head of global technology business development; Dr John D'Errico will lead the company's commercial merchandising operations and previously served at VWR Scientific; Kara Cannon joins as head of global marketing after ten years at Pall Corporation; and Dr Paul Munger, previously an executive at Pierce Chemical, joins to lead Enzo's global manufacturing operations.